{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:47:41Z","timestamp":1791316061921,"version":"4.3.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This systematic review aims to assess the efficacy and safety of percutaneous aspiration and sclerotherapy (PAS) for patients with symptomatic simple hepatic cysts (SHCs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      We systematically searched the electronic databases of PubMed, Embase, the Cochrane Library and Ichushi-Web for studies published up to November 2024, reporting outcomes of PAS for symptomatic SHCs. The primary outcomes were rates of symptomatic relief or disappearance of symptoms. The secondary outcomes were cyst volume reduction rates and complication rates. Subgroup analyses compared ethanol with the other sclerosants. Single-arm meta-analyses were performed, with meta-regression conducted when substantial heterogeneity (\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009&gt;\u200950%) was observed. Risk of bias was assessed using the Cochrane RoB2 tool for randomized controlled trials and RoBANS2 for non-randomized studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sixteen studies were included. Fourteen studies were assessed as having a high risk of bias. The pooled symptomatic relief or disappearance rate was 86.9% (95% CI 80.2\u201391.6%,\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090%). The cyst volume reduction rate was 86.4% (95% CI 74.1\u201393.3%,\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200995%). There were no major complications. The pooled minor complication rates were 13.6% (95% CI 6.5\u201326.4%,\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200967.2%) for pain and 7.4% (95% CI 4.1\u201313.0%,\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200938%) for fever. Subgroup analysis showed no significant differences between ethanol and other sclerosants. High heterogeneity was observed for cyst volume reduction and pain, indicating variability across studies. Meta-regression analysis for cyst volume reduction rate and pain did not identify any significant associations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PAS appears to be a relatively safe and effective treatment option for patients with symptomatic SHCs and provides high rates of symptomatic relief with low complication rates. However, given the high risk of bias in the available evidence and the lack of direct comparison with surgical treatment, these findings should be interpreted with caution. Further high-quality comparative studies are warranted to confirm these results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11604-025-01874-7","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:14:04Z","timestamp":1759227244000},"page":"168-182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Percutaneous aspiration and sclerotherapy for simple hepatic cysts: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2375-4919","authenticated-orcid":false,"given":"Tomohiro","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Yoshimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junki","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Yamanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"1874_CR1","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0009-9260(03)00165-X","volume":"58","author":"ZI Carrim","year":"2003","unstructured":"Carrim ZI, Murchison JT. The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol. 2003;58:626\u20139.","journal-title":"Clin Radiol"},{"key":"1874_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijsu.2015.11.051","volume":"25","author":"T Debs","year":"2016","unstructured":"Debs T, Kassir R, Reccia I, Elias B, Ben Amor I, Iannelli A, et al. Technical challenges in treating recurrent non-parasitic hepatic cysts. Int J Surg. 2016;25:44\u20138.","journal-title":"Int J Surg"},{"key":"1874_CR3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s00330-007-0760-5","volume":"18","author":"E Zerem","year":"2008","unstructured":"Zerem E, Imamovi\u0107 G, Omerovi\u0107 S. Percutaneous treatment of symptomatic non-parasitic benign liver cysts: single-session alcohol sclerotherapy versus prolonged catheter drainage with negative pressure. Eur Radiol. 2008;18:400\u20136.","journal-title":"Eur Radiol"},{"key":"1874_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.hpb.2020.07.005","volume":"23","author":"A Furumaya","year":"2021","unstructured":"Furumaya A, van Rosmalen BV, de Graeff JJ, Haring MPD, de Meijer VE, van Gulik TM, et al. Systematic review on percutaneous aspiration and sclerotherapy versus surgery in symptomatic simple hepatic cysts. HPB (Oxford). 2021;23:11\u201324.","journal-title":"HPB (Oxford)"},{"key":"1874_CR5","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/ajg.2014.213","volume":"109","author":"JA Marrero","year":"2014","unstructured":"Marrero JA, Ahn J, Rajender Reddy K. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol. 2014;109:1328\u201347 (quiz 48).","journal-title":"Am J Gastroenterol"},{"key":"1874_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2214\/ajr.144.2.237","volume":"144","author":"WJ Bean","year":"1985","unstructured":"Bean WJ, Rodan BA. Hepatic cysts: treatment with alcohol. AJR Am J Roentgenol. 1985;144:237\u201341.","journal-title":"AJR Am J Roentgenol"},{"key":"1874_CR7","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1007\/BF02087673","volume":"39","author":"N Yamada","year":"1994","unstructured":"Yamada N, Shinzawa H, Ukai K, Makino N, Matsuhashi T, Wakabayashi H, et al. Treatment of symptomatic hepatic cysts by percutaneous instillation of minocycline hydrochloride. Dig Dis Sci. 1994;39:2503\u20139.","journal-title":"Dig Dis Sci"},{"key":"1874_CR8","first-page":"496","volume":"45","author":"HM Lopes","year":"1998","unstructured":"Lopes HM, Portela FA, e Silva Pontes JM, Leit\u00e3o MJ, Ribeiro JC, Freitas DS. Treatment of benign hepatic cysts by instillation of tetracycline hydrochloride. Hepatogastroenterology. 1998;45:496\u20139.","journal-title":"Hepatogastroenterology"},{"key":"1874_CR9","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00270-017-1703-4","volume":"40","author":"DK Filippiadis","year":"2017","unstructured":"Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the Cirse classification system. Cardiovasc Intervent Radiol. 2017;40:1141\u20136.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1874_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"1874_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4082\/kjfm.23.0034","volume":"44","author":"H-J Seo","year":"2023","unstructured":"Seo H-J, Kim SY, Lee YJ, Park J-E. RoBANS 2: a revised risk of bias assessment tool for nonrandomized studies of interventions. Korean J Fam Med. 2023;44:249.","journal-title":"Korean J Fam Med"},{"key":"1874_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12:55\u201361.","journal-title":"Res Synth Methods"},{"key":"1874_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1155\/1994\/10372","volume":"8","author":"M Montorsi","year":"1994","unstructured":"Montorsi M, Torzilli G, Fumagalli U, Bona S, Rosati R, De Simone M, et al. Percutaneous alcohol sclerotherapy of simple hepatic cysts. Results from a multicentre survey in Italy. HPB Surg. 1994;8:89\u201394.","journal-title":"HPB Surg"},{"key":"1874_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1148\/radiology.206.1.9423674","volume":"206","author":"C Cellier","year":"1998","unstructured":"Cellier C, Cuenod CA, Deslandes P, Auroux J, Landi B, Siauve N, et al. Symptomatic hepatic cysts: treatment with single-shot injection of minocycline hydrochloride. Radiology. 1998;206:205\u20139.","journal-title":"Radiology"},{"key":"1874_CR15","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3109\/02841859909175601","volume":"40","author":"TB Larssen","year":"1999","unstructured":"Larssen TB, Jensen DK, Viste A, Horn A. Single-session alcohol sclerotherapy in symptomatic benign hepatic cysts. Long-term results. Acta Radiol. 1999;40:636\u20138.","journal-title":"Acta Radiol"},{"key":"1874_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1386-6346(99)00067-4","volume":"17","author":"A Okano","year":"2000","unstructured":"Okano A, Hajiro K, Takakuwa H, Nishio A. Alcohol sclerotherapy of hepatic cysts: its effect in relation to ethanol concentration. Hepatol Res. 2000;17:179\u201384.","journal-title":"Hepatol Res"},{"key":"1874_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1440-1746.2003.03025.x","volume":"18","author":"H Yoshida","year":"2003","unstructured":"Yoshida H, Onda M, Tajiri T, Arima Y, Mamada Y, Taniai N, et al. Long-term results of multiple minocycline hydrochloride injections for the treatment of symptomatic solitary hepatic cyst. J Gastroenterol Hepatol. 2003;18:595\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"1874_CR18","first-page":"35","volume":"65","author":"R Jusufovic","year":"2011","unstructured":"Jusufovic R, Zerem E. Percutaneous treatment of symptomatic non-parasitic benign liver cysts with 20% NaCl solution. Med Arh. 2011;65:35\u20137.","journal-title":"Med Arh"},{"key":"1874_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.4318\/tjg.2012.0349","volume":"23","author":"F Yan-Hong","year":"2012","unstructured":"Yan-Hong F, Lin-Xue Q, Hai-Ma G, Qing Z, Yu G, Xiangdong H. Sclerotherapy of simple hepatic cysts by repeated aspiration and alcohol instillation. Turk J Gastroenterol. 2012;23:359\u201365.","journal-title":"Turk J Gastroenterol"},{"key":"1874_CR20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.11152\/mu.2014.2066.161.zs1pr2","volume":"16","author":"Z Sp\u00e2rchez","year":"2014","unstructured":"Sp\u00e2rchez Z, Radu P, Zaharie F, Al Hajjar N, Sp\u00e2rchez M. Percutaneous treatment of symptomatic non-parasitic hepatic cysts. Initial experience with single-session sclerotherapy with polidocanol. Med Ultrasonography. 2014;16:222\u20138.","journal-title":"Med Ultrasonography"},{"key":"1874_CR21","doi-asserted-by":"publisher","first-page":"489363","DOI":"10.1155\/2015\/489363","volume":"2015","author":"VD Souftas","year":"2015","unstructured":"Souftas VD, Kosmidou M, Karanikas M, Souftas D, Menexes G, Prassopoulos P. Symptomatic abdominal simple cysts: Is percutaneous sclerotherapy with hypertonic saline and bleomycin a treatment option? Gastroenterol Res Practi. 2015;2015:489363.","journal-title":"Gastroenterol Res Practi"},{"key":"1874_CR22","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ejrnm.2018.04.005","volume":"49","author":"AM Abd El-Khalek","year":"2018","unstructured":"Abd El-Khalek AM, El-Sayed NTM, Elalfy H, Besheer T, Farid K, ElAgezy M, et al. Percutaneous US-guided combined ethanol and tetracycline injection for treating symptomatic simple and hydatid hepatic cysts. Egypt J Radiol Nucl Med. 2018;49:797\u2013803.","journal-title":"Egypt J Radiol Nucl Med"},{"key":"1874_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/hepr.13769","volume":"52","author":"Y Eso","year":"2022","unstructured":"Eso Y, Shimizu H, Takai A, Takahashi K, Seno H. Ultrasound-guided polidocanol foam sclerotherapy for symptomatic giant hepatic cyst: a single-center experience. Hepatol Res. 2022;52:557\u201365.","journal-title":"Hepatol Res"},{"key":"1874_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.737694","author":"Z Mo","year":"2022","unstructured":"Mo Z, Yang F, Lv L, He J, Gou Q, Chen X, et al. Comparison of the efficacy and safety of single-session OK-432 and multiple-session 99% ethanol sclerotherapy for symptomatic simple hepatic cysts. Front Med. 2022. https:\/\/doi.org\/10.3389\/fmed.2022.737694.","journal-title":"Front Med"},{"key":"1874_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3164\/jcbn.22-89","volume":"72","author":"S Kinoshita","year":"2023","unstructured":"Kinoshita S, Nishizawa T, Tojo M, Hirai Y, Nakazato Y, Miyanaga R, et al. Simple drainage versus drainage with minocycline infusion for symptomatic hepatic cysts. J Clin Biochem Nutr. 2023;72:89\u201391.","journal-title":"J Clin Biochem Nutr"},{"key":"1874_CR26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.7863\/jum.1998.17.8.531","volume":"17","author":"RK Gelczer","year":"1998","unstructured":"Gelczer RK, Charboneau JW, Hussain S, Brown DL. Complications of percutaneous ethanol ablation. J Ultrasound Med. 1998;17:531\u20133.","journal-title":"J Ultrasound Med"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01874-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-025-01874-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01874-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:33:41Z","timestamp":1767591221000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-025-01874-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1874"],"URL":"https:\/\/doi.org\/10.1007\/s11604-025-01874-7","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original publication has been updated for inclusion of Supplementary information","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable. This study did not involve human participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}